Stock MOLNRIPO J. MOLNER
Add to a list
To use this feature you must be a member
Log inSign up

All News J. Molner

Equities

MOLNRIPO

EE3100109034

Delayed Nasdaq Tallinn
Other stock markets
 09:30:00 2024-07-12 am EDT 		5-day change 1st Jan Change
15.3 EUR -3.16% Intraday chart for J. Molner +2.68% +11.27%
Apr. 30 J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4% CI
Mar. 04 J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
J. Molner AS Gains US FDA Approval for First Estonian-Developed ANDA - Lidocaine Hydrochloride Topical Solution 4%
CI
J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services
CI
Certain Ordinary Shares of J. Molner AS are subject to a Lock-Up Agreement Ending on 7-NOV-2023.
CI
J. Molner AS Signs Licensing Agreement for Five Approved Drugs in the US
CI
J. Molner AS has completed an IPO in the amount of Ç1.199998 million.
CI
J. Molner AS has filed an IPO in the amount of Ç1.199998 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOLNRIPO Stock
  4. News J. Molner